Bio-Gate AG (FRA: BIG1)

Market Cap	8.22M
Revenue (ttm)	7.57M
Net Income (ttm)	-2.00M
Shares Out	9.24M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	0.575 - 1.700
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 9, 2024

About Bio-Gate AG

Bio-Gate AG provides technologies and customized solutions for health and hygiene in Germany. The company offers HyProtect, a plasma coating, which protects the surfaces of medical implants against bacterial colonization. It also provides MicroSilver BG elemental microporous silver additives. The company’s products are used in large and medium-sized medical technology companies, pharmaceutical distributors, distribution companies, industrial companies, public sector companies, and hygiene-sensitive institutions. The company was founded in 2005 ...

• Industry: Miscellaneous Chemical Products
• Founded: 2005
• Employees: 42
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BIG1

Financial Performance

In 2023, Bio-Gate AG's revenue was 7.31 million, an increase of 19.52% compared to the previous year's 6.11 million. Losses were -1.62 million, -10.20% less than in 2022.